Keyphrases
Mammary Tumor
100%
Tumor Microenvironment
100%
NF-B
100%
Janus Kinase Inhibitors
100%
Tumor Cells
66%
Gene Expression
33%
Breast Cancer
33%
Tumor
33%
Tumor Growth
33%
Ruxolitinib
33%
Targeted Therapy
33%
Breast Cancer Cells
33%
Tumor Progression
33%
Macrophages
33%
Tumor Response
33%
Oncogenic Signaling
33%
Chemotherapy Resistance
33%
Resistance Mechanisms
33%
Tumor-associated Macrophages
33%
Response to Therapy
33%
Janus Kinase-signal Transducer
33%
Tumor Growth in Vivo
33%
Transcription Pathways
33%
Medicine and Dentistry
Breast Tumor
100%
Tumor Microenvironment
100%
Janus Kinase Inhibitor
100%
Breast Cancer
66%
Neoplasm
66%
Tumor Progression
66%
Tumor Cell
66%
Macrophage
66%
Cancer Cell
33%
Targeted Therapy
33%
Ruxolitinib
33%
Signal Transduction
33%
Janus Kinase
33%
Biochemistry, Genetics and Molecular Biology
Tumor Progression
100%
Janus Kinase Inhibitor
100%
Signal Transduction
50%
Macrophage
50%
Transcription
50%
Cancer Cell
50%
Ruxolitinib
50%
Janus Kinase
50%
Tumor-Associated Macrophage
50%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Tumor
100%
Neoplasm
100%
Janus Kinase Inhibitor
100%
Tumor Microenvironment
75%
Breast Cancer
50%
Tumor Growth
50%
Janus Kinase
25%
Ruxolitinib
25%
Immunology and Microbiology
Tumor Cell
100%
Macrophage
50%
Tumor-Associated Macrophage
50%
Cancer Cell
50%
Signal Transduction
50%